Compugen (CGEN) Long-Term Investments (2010 - 2015)
Compugen's (CGEN) quarterly Long-Term Investments came in at $2.0 million in Q1 2015, down 7.12% year-on-year from $2.2 million in Q1 2014, and down 0.79% quarter-over-quarter from $2.0 million in Q4 2014.
Compugen (CGEN) Long-Term Investments (2010 - 2015) Analysis & Trends
Compugen has disclosed Long-Term Investments across 6 years of filings, most recently posting $2.0 million for Q1 2015.
- Long-Term Investments for Q1 2015 came in at $2.0 million, down 7.12% year-over-year; the trailing twelve-month figure through Mar 2015 was $2.0 million (down 7.12% YoY), and the FY2014 annual result was $2.0 million, down 4.93% from the prior year.
- Long-Term Investments came in at $2.0 million for Q1 2015 at Compugen, down from $2.0 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $5.6 million in Q4 2011 to a low of $1.7 million in Q4 2012.
- The 5-year median for Long-Term Investments is $2.0 million (2014), against an average of $2.3 million.
- Across the five-year window, Long-Term Investments sank 69.0% in 2012 and increased 23.21% in 2013, its largest moves.
- Compugen's Long-Term Investments stood at $5.6 million in 2011, then tumbled by 69.0% to $1.7 million in 2012, then climbed by 23.21% to $2.1 million in 2013, then decreased by 4.93% to $2.0 million in 2014, then retreated by 0.79% to $2.0 million in 2015.
- The last three Long-Term Investments figures came in at $2.0 million (Q1 2015), $2.0 million (Q4 2014), and $2.1 million (Q3 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 2.01 Mn |
| Dec 31, 2014 | 2.02 Mn |
| Sep 30, 2014 | 2.08 Mn |
| Jun 30, 2014 | 2.26 Mn |
| Mar 31, 2014 | 2.16 Mn |
| Dec 31, 2013 | 2.13 Mn |
| Sep 30, 2013 | 2.01 Mn |
| Jun 30, 2013 | 1.92 Mn |
| Mar 31, 2013 | 1.88 Mn |
| Dec 31, 2012 | 1.73 Mn |
| Dec 31, 2011 | 5.58 Mn |
| Dec 31, 2010 | 7.80 Mn |